Greek Hotel Named Best All-Inclusive in the World by TripAdvisor
” width=”696″>An aerial view of stunning Tigana beach in Halkidiki, where both of the best hotels in Greece are located. Credit: Nicolas Hadjidimitriou /Wikimedia Commons/CC BY-SA 4.0
The TripAdvisor Traveler’s Choice Awards recently named a Greek hotel as the best all-inclusive on the entire globe for 2021. The prestigious award was also bestowed on a second hotel in Greece, as it was voted the third best hotel in the entire world by travelers.
The awards, which were released in January, are regarded as some of the most reliable in the industry because they rely solely on customer experience and ratings in contrast to other hotel awards which are often decided using expert opinions, which may not align with customer needs.
佩莱集团启动全球卓越伙伴计划,与科丝美诗集团签署战略合作协议_产业综合_行业_中金在线
cnfol.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnfol.com Daily Mail and Mail on Sunday newspapers.
【财富周报】35家券商投资能力榜出炉，资管Nippon Wealth将结束香港服务
sina.com.cn - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.cn Daily Mail and Mail on Sunday newspapers.
Representational image. | Bulent Kilic / AFP
Last week, a German vaccine advisory committee recommended the AstraZeneca vaccine only be used in 18-year to 64-year-olds, citing a lack of data on the efficacy of the vaccine in people over 65 years.
Subsequently, the European regulator, the European Medicines Agency, conditionally approved the vaccine for anyone over 18.
What can we make of this? Should we be giving this vaccine to older people or not?
While we do not yet have all the data we would like, we do not have reason to believe this vaccine will not be at least somewhat effective in older adults. To exclude them from receiving it would not necessarily be the right approach.
Photo: Verwendung weltweit/ AFP
The European Commission said it was trying to obtain more information.
This comes on top of a halt to vaccinations in some parts of Europe due to a cut in deliveries of the Pfizer-BioNTech vaccine.
AstraZeneca, which developed its vaccine with Oxford University, disclosed the situation in a statement, but gave few details. Initial volumes will be lower than originally anticipated due to reduced yields at a manufacturing site within our European supply chain, it said.
Reuters news agency quotes an unnamed EU official as saying that the company had told the EU that the supply would reduce to 31 million - a cut of 60 percent - the number of doses it could deliver to the bloc in the first quarter of this year.